Artigos

Search for articles

BJO Oncology - Placeholder

Risk factors for central venous catheter-related bloodstream infection in oncology patients: an integrative review

ABSTRACT The aim of this integrative review was to identify scientific studies on risk factors for bloodstream infections associated with central venous catheters (CVC) in cancer patients. The research question was formulated according to the PICO framework. An electronic search was conducted on the SciELO digital library, the Virtual Health...
BJO Oncology - Placeholder

Prognostic factors in inpatients with advanced cancer at a palliative care unit

ABSTRACT Objectives: This study aims to identify prognostic factors and their discriminatory ability in inpatients with advanced cancer at a palliative care unit (PCU). Material and Methods: Observational, prospective cohort study involving advanced cancer patients (October 2019 to May 2021) of their first admission to a PCU. Sociodemographic, clinical, functional, nutritional, and...
BJO Oncology - Placeholder

Analysis of the hemotherapy support in an oncology hospital considering the COVID-19 pandemic

ABSTRACT Objectives: The purpose of this study was to analyze the impact of COVID-19 on the use of blood components in an oncology hospital. Material and Methods: Retrospective cross-sectional quantitative nature cohort, with comparative analysis of blood component requests by an oncology hospital in the city of Juiz de Fora, Minas Gerais,...
BJO Oncology - Placeholder

Initial experience of irreversible electroporation ablation in Brazil: a retrospective analysis

ABSTRACT Introduction: The objective of our study is to present the first Brazilian irreversible electroporation experience in the treatment of solid cancer. Material and Methods: A retrospective study with the first ten patients who underwent percutaneous or surgical IRE to treat solid cancer between March 2021 and May 2021. Preoperative data collection...
BJO Oncology - Placeholder

Assessment of body mass index and its relationship with breast cancer survival in a clinical oncology service in the Federal District

ABSTRACT Objective: The purpose of this study was to analyze the relationship between obesity and clinical outcomes in breast cancer patients by evaluating the mean body mass index (BMI) and overall survival. Material and Methods: The research's method consisted of a retrospective observational and descriptive study without intervention, carried out in a...
BJO Oncology - Placeholder

METABOLOMIC APPROACHES APPLIED TO THE STUDY OF CERVICAL CANCER: A SYSTEMATIC REVIEW

ABSTRACT Background: Cervical cancer (CC) is the fourth leading cause of cancer among women in the world. Metabolomics can provide a deeper understanding of the underlying metabolic alterations associated with its pathophysiology. Objective: To systematically analyze metabolomic approaches and findings used in the study of cervical cancer. Selection Criteria: Studies that included the...
BJO Oncology - Placeholder

Clinical characterization of the Dermatofibrosarcomas at Barretos Cancer Hospital in São Paulo

ABSTRACT Introduction: Dermatofibrosarcoma (DFSP) is a rare neoplasia from mesenchymal tissues in the skin. It has a high potential for local invasion and a high rate of recurrence after the surgical excision. It appears as a hardened plaque of violaceous color, asymptomatic, which evolves with protuberant nodules. There are few Brazilian...
BJO Oncology - Placeholder

Delayed and sequencial hemolytic uremic syndrome as a complication of Gemcitabine therapy

ABSTRACT Gemcitabine is a widely used drug in the treatment of diverse malignancies and its use has been approved by the US Food and Drug Administration. This drug has been associated with a rare adverse event, the Hemolytic Uremic Syndrome (HUS), characterized by acute kidney injury, microangiopathic hemolytic anemia, and...
BJO Oncology - Placeholder

Uterine rupture secondary to undiagnosed placental site trophoblastic tumor: case report

ABSTRACT Placental site trophoblastic tumor is a rare and malignant form of gestational trophoblastic disease. Its incidence rate is 1/50.000-100.000 pregnancies and accounts for less than 3% of all cases of gestational trophoblastic disease. In addition to its infrequency, the tumor lacks pathognomonic sonographic features, delaying diagnosis until immunohistochemical staining...
BJO Oncology - Placeholder

Changes in inflammatory biomarkers related to C-reactive protein and albumin in patients with terminal cancer receiving palliative care: a longitudinal study.

ABSTRACT Background: Evidence about how inflammatory biomarkers vary during the end-stage cancer trajectory is lacking. This study investigates the longitudinal changes in albumin and C-reactive protein (CRP) levels, and CRP/albumin ratio (CAR) in patients with terminal cancer receiving palliative care in the last three months of life. Methods: This is a retrospective...